Literature DB >> 6341054

Structure of the 2-keto-3-deoxy-D-manno-octonic-acid-containing capsular polysaccharide (K12 antigen) of the urinary-tract-infective Escherichia coli O4:K12:H-.

M A Schmidt, K Jann.   

Abstract

The primary structure of the K12 antigenic capsular polysaccharide (K12 antigen) of Escherichia coli O4:K12:H- was elucidated by composition, nuclear magnetic resonance spectroscopy, methylation, periodate oxidation and oligosaccharide analysis. The polysaccharide consists of repeating trisaccharide alpha-rhamnosyl-1,2-alpha-rhamnosyl-1,5-dOclA units (dOclA = 2-keto-3-deoxy-D-manno-octonic acid) which are joined through beta-2,3-linkages. About 50% of the dOclA units are O-acetylated at C7 or C8. The sequence of acetylated and non-acetylated dOclA residues is not known. As had been reported before, the polysaccharide is linked to a phosphatidic acid at the reducing end (dOclA) via a phosphodiester bridge. The serologically specific part of the K12 antigen is its polysaccharide moiety.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341054     DOI: 10.1111/j.1432-1033.1983.tb07291.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  The Haemophilus influenzae Type b hcsA and hcsB gene products facilitate transport of capsular polysaccharide across the outer membrane and are essential for virulence.

Authors:  Soila Sukupolvi-Petty; Susan Grass; Joseph W St Geme
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

2.  Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli.

Authors:  Dounia Houamel; Nicolas Ducrot; Thibaud Lefebvre; Raed Daher; Boualem Moulouel; Marie-Agnes Sari; Philippe Letteron; Said Lyoumi; Sarah Millot; Jerome Tourret; Odile Bouvet; Sophie Vaulont; Alain Vandewalle; Erick Denamur; Hervé Puy; Carole Beaumont; Laurent Gouya; Zoubida Karim
Journal:  J Am Soc Nephrol       Date:  2015-08-20       Impact factor: 10.121

3.  Activation of human neutrophils by mycobacterial phenolic glycolipids.

Authors:  J Fäldt; C Dahlgren; A Karlsson; A M Ahmed; D E Minnikin; M Ridell
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

4.  Characterization of the capsular polysaccharide of Burkholderia (Pseudomonas) pseudomallei 304b.

Authors:  H Masoud; M Ho; T Schollaardt; M B Perry
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

5.  Molecular cloning and analysis of genes for production of K5, K7, K12, and K92 capsular polysaccharides in Escherichia coli.

Authors:  I Roberts; R Mountford; N High; D Bitter-Suermann; K Jann; K Timmis; G Boulnois
Journal:  J Bacteriol       Date:  1986-12       Impact factor: 3.490

6.  Further electron microscopic studies on the expression of Escherichia coli group II capsules.

Authors:  K D Kröncke; J R Golecki; K Jann
Journal:  J Bacteriol       Date:  1990-06       Impact factor: 3.490

7.  Conserved glycolipid termini in capsular polysaccharides synthesized by ATP-binding cassette transporter-dependent pathways in Gram-negative pathogens.

Authors:  Lisa M Willis; Jacek Stupak; Michele R Richards; Todd L Lowary; Jianjun Li; Chris Whitfield
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

8.  KpsC and KpsS are retaining 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) transferases involved in synthesis of bacterial capsules.

Authors:  Lisa M Willis; Chris Whitfield
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-03       Impact factor: 11.205

9.  Crossreactions of Escherichia coli K and O polysaccharides in antipneumococcal and anti-Salmonella sera.

Authors:  M Heidelberger; K Jann; B Jann
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

10.  Chemical structure and genetic organization of the E. coli O6:K15 capsular polysaccharide.

Authors:  Hugo F Azurmendi; Vamsee Veeramachineni; Stephen Freese; Flora Lichaa; Darón I Freedberg; Willie F Vann
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.